Track Categories

The track category is the heading under which your abstract will be reviewed and later published in the conference printed matters if accepted. During the submission process, you will be asked to select one track category for your abstract.

Neurobiology is the study of cells of the nervous system and the organization of these cells into functional circuits that process information and mediate behaviour. It is a subdiscipline of both biology and neuroscience. Neurobiology differs from neuroscience, a much wider field that is concerned with any scientific study of the nervous system. Neurons are cells that are specialized to receive, propagate, and transmit electrochemical impulses. In the human brain alone, there are over a hundred billion neurons. Neurons are diverse with respect to morphology and function.


  • Track 1-1Neuroanatomy
  • Track 1-2Neural Communication
  • Track 1-3Perception
  • Track 1-4Motor Control
  • Track 1-5Homeostasis

Central Nervous system (CNS) plays a major role in awareness, movements, sensations, thoughts, speech and memory. It is accountable for integrating sensory information and responding accordingly. The spinal cord serves as a channel for signals between the brain and the rest of the body. It also controls simple musculoskeletal impulses without input from the brain. Neurological disorders are diseases that affect the brain and the central and autonomic nervous systems. In spotting the signs and symptoms of neurological disorders, it is first important to differentiate the different types of neurological disorders


  • Track 2-1Bipolar Disorder
  • Track 2-2Neuropathic Pain Syndromes
  • Track 2-3Accessory Nerve Disorder
  • Track 2-4CNS Disorder and Structural Defects
  • Track 2-5Facial Nerve Paralysis
  • Track 2-6Meningitis
  • Track 2-7Therapies for Genetic Disorders

Alzheimer’s disease (AD) is a chronic neurodegenerative disease that usually starts slowly and degenerates over time. Alzheimer’s is the major cause of 60% to 70% cases of dementia. The most common initial symptom is difficulty in remembering recent events, short-term memory loss. As the disease advances, symptoms can include problems with language, confusion (including easily getting lost), mood swings, loss of motivation, not managing self-care, and behavioural issues. As a person's state declines, they often withdraw from family and society. Gradually, bodily functions are lost, ultimately leading to death

  • Track 3-1Alzheimer’s Disease and Dementia
  • Track 3-2Biomarkers
  • Track 3-3Logopenic Progressive Aphasia
  • Track 3-4Alzheimer’s Disease: Diagnosis and Symptoms
  • Track 3-5Neuroimaging
  • Track 3-6Posterior Cortical Atrophy

Parkinson’s disease is a dynamic neurological disorder that impacts how the individual moves, including how they talk and compose. It develops gradually, at times starting with a hardly distinguishable tremor in just a single hand. In any case, while a shock may be the most surely understood indication of Parkinson's infection, the turmoil in like manner frequently causes strength or directing of advancement. The major cause of the disease is due to low dopamine levels. People with Parkinson’s disease also experience stiffness and they find abnormality in carrying out the movements as rapidly as before- this is known as bradykinesia

  • Track 4-1Epidemiology of Parkinsons
  • Track 4-2Clinical Features, Treatment and Pathology
  • Track 4-3Cognitive Stimulation Therapy (CST)
  • Track 4-4Free Radicles and Aging in Parkinsons
  • Track 4-5Neuroinflammation
  • Track 4-6Autophagy/Lysosomal Dysfunction
  • Track 4-7Psychology of Parkinsons Patients

Huntington's disease is a genetic disease that causes the advanced breakdown (degeneration) of nerve cells in the brain. Huntington's disease has a wide impact on a person's functional abilities and usually results in movement, thinking (cognitive) and psychiatric disorders. Most people with Huntington's disease progress signs and symptoms in their 30s or 40s. But the disease may develop earlier or later in life. When the disease progresses before age 20, the condition is called juvenile Huntington's disease. An earlier development of the disease often results in a somewhat different set of symptoms and faster disease progression. Medications are available to help manage the symptoms of Huntington's disease, but treatments can't prevent the physical, mental and behavioural decline associated with the condition

  • Track 5-1Neuronal Replacement
  • Track 5-2Transcriptional Dysregulation
  • Track 5-3Cognitive Behavioural Therapy
  • Track 5-4Psychiatric Disorders
  • Track 5-5Symptoms of Juvenile Huntingtons Disease

The human nervous system performs significantly diverse and highly complex functions: It oversees the functions of all bodily organs; it receives and integrates information from all senses; it initiates and coordinates motor activities; and particularly, it processes our thoughts, generates our emotions, and stores our memories. Billions of cells are organized, characterized, and specialized to carry out these functions. The neurons are the administrators, the glial cells provide adequate environment, the blood vessels furnish nutrients, and the meninges protect from injuries. The neurons, glial cells, blood vessels, and meninges each has a diverse morphology and shows characteristic changes in diseases. Neuropathology is the study of characteristic reactions of neural tissue to diseases and the pathologic conditions particular to the nervous system

  • Track 6-1Developmental Neuropathology
  • Track 6-2Brain Tumour Pathology
  • Track 6-3Pediatric Disease & Epilepsy
  • Track 6-4Vascular Disease and Trauma
  • Track 6-5Dynamic, Molecular and Epidemiological Neuropathology
  • Track 6-6Deciphering Tau Neuropathology

Neuroimaging or brain imaging is the use of various techniques to either directly or indirectly image the structure, function/pharmacology of the nervous system. It is a relatively new discipline within medicine, neuroscience, and psychology. Neuroimaging is broadly categorised as structural imaging and functional imaging. Structural imaging deals with the structure of the nervous system and the diagnosis of gross (large scale) intracranial disease (such as a tumor) and injury. Functional imaging is used to diagnose metabolic diseases and lesions on a finer scale (such as Alzheimer's disease) and also for neurological and cognitive psychology research and building brain-computer interfaces. Functional imaging enables, for example, the processing of information by centers in the brain to be visualized directly. Such processing causes the involved area of the brain to increase metabolism and "light up" on the scan

  • Track 7-1Anatomical Imaging
  • Track 7-2Musculoskeletal Imaging
  • Track 7-3Brain Imaging Techniques
  • Track 7-4Structural and Molecular Biomarkers
  • Track 7-5Neuroimaging Biomarkers for Early Detection of Alzheimer’s Disease

Epilepsy is a condition characterized by recurrent seizures due to a disorder of the brain cells. It is a life-long tendency, though the seizures may start at any time during life and occur periodically or frequently. Some of the epilepsies are confined to particular age groups. Some suffer from it their whole lives and others only for a few years (average approximately 13 years). Epilepsy may develop after an identifiable event (e.g., asphyxia, head injury, meningitis), in which case it is called symptomatic epilepsy, or it may develop without any identifiable cause, and then it is called idiopathic epilepsy

  • Track 8-1Etiology of Epilepsy
  • Track 8-2Epilepsy Therapeutics
  • Track 8-3Epilepsy Syndromes
  • Track 8-4Genetic Epilepsies
  • Track 8-5Disorders of Epilepsy
  • Track 8-6Synchrony in Normal and Epileptic Brain

Injuries to the central nervous system (the brain and spinal cord) are a heterogeneous group of pathologic disorders. They can be categorized by mechanisms of injury, clinical severity, radiological appearance, or anatomic distribution. Neurotrauma continues to be a significant cause of morbidity and mortality. Neurologic injury from trauma not only results from the initial physical insult but also continues to occur in the ensuing hours or days. Prevention of primary neurologic injury from trauma is the focus of public health efforts such as the use of helmets and seatbelts. A major component in the management of patients with neurotrauma is the prevention of secondary injury such as ischemia and hypoxia

  • Track 9-1Pathological Features
  • Track 9-2Signs and Symptoms
  • Track 9-3Mechanism of Traumatic Brain Injury
  • Track 9-4Recent Advances in Brain Trauma
  • Track 9-5Diagnosis
  • Track 9-6Prevention and Treatment
  • Track 9-7Epidemology

Neuroimunology is the combination of study of both neuroscience and immunology. Mass cytometry, or CyTOF (cytometry by time-of-flight), is a common technique applied to the discovery of novel immune populations in humans and rodents. Neuroinfectious diseases affect the nervous system, from the brain and spinal cord to muscles and nerves. There are a wide range of neuroinfectious diseases, including: Meningitis and encephalitis, Progressive multifocal leukoencephalopathy, HIV-associated neurodegeneration and neurosarcoidosis, HTLV 1 myelopathy hereditary spastic paraparesis, a progressive disease of the spinal cord resulting in painfully stiff, weak legs. Transverse myelitis, an inflammation of both sides of the spinal cord that can cause pain, weakness, paralysis, sensory problems, or bladder and bowel dysfunction. Treatments for these diseases may include antiviral, antibacterial, anti-inflammatory or anticonvulsive medicines, among other approaches

  • Track 10-1Multiple sclerosis
  • Track 10-2Auto Immune Neuropathies
  • Track 10-3Auto Immune Neuropathies
  • Track 10-4Neuroimmuno Genetics
  • Track 10-5Meningeal Carcinomatosis
  • Track 10-6Neurovirology
  • Track 10-7Neuroinflamation
  • Track 10-8Neuroinfectious Disease
  • Track 10-9Neuromodulation Alteration
  • Track 10-10Novel Drug Development

The Molecular and Cellular Basis of Neurodegenerative Diseases: Fundamental Mechanisms presents the pathology, genetics, biochemistry and cell biology of the major human neurodegenerative diseases, including Alzheimer’s, Parkinson’s, frontotemporal dementia, ALS, Huntington’s, and prion diseases. The most common form of senile dementia is Alzheimer’s disease (AD), which is characterized by the extracellular deposition of amyloid β-peptide (Aβ) plaques and the intracellular formation of neurofibrillary tangles (NFTs) in the cerebral cortex. Tau abnormalities are commonly observed in many neurodegenerative diseases including AD, Parkinson’s disease, and Pick’s disease

  • Track 11-1Molecular Bases of Neurological Diseases
  • Track 11-2Cognitive and Emotional Deficits
  • Track 11-3Anatomical and Functional Basis of Dementia and Neurodegeneration
  • Track 11-4Mitochondria and Protein Quality Control Dysfunction
  • Track 11-5RNA and DNA Regulatory Proteins
  • Track 11-6Bridging Biology to Therapeutics
  • Track 11-7Prion and Prion-Like Contributions to Neurodegeneration
  • Track 11-8Inducible Pluripotent Stem Cells

Natural products derived from plants, marines, animals, fungal and bacterial are known and active since prehistoric times for their therapeutic properties. Natural products endure to provide useful drugs in their own right but also provide patterns for the development of other compounds. The health benefits that these natural products availabilities have become a motive for treatment studies of various diseases. Natural products have long been used for the relief of neurological symptoms, yet their mechanisms of action remain intangible. Current researches have started to reveal the complex molecular events associated with the therapeutic effects of natural products in neurodegenerative diseases

  • Track 12-1Epigenetic Modification
  • Track 12-2Effect of Docosahexaenoic Acid (DHA) on Spinal Cord Injury
  • Track 12-3Application of Bioactive Compounds
  • Track 12-4Natural Polyphenols
  • Track 12-5Efficacy of Natural Compounds
  • Track 12-6Plant derived Natural Products

Neuromuscular diseases are those which impair the functioning of muscles either directly by affecting the voluntary muscles or by affecting the nerves or neuromuscular junctions. Neuromuscular disease can be instigated by autoimmune disorders, genetic/hereditary disorders and some forms of the collagen disorder. A form of muscle weakness due to antibodies against certain receptor is the major cause of neuromuscular disease. The mechanism of neurological diseases depends on whether it is amyotrophic lateral sclerosis, myasthenia gravis or some other NMD. The muscular disorders may be revealed by the diagnostic procedures that include direct clinical observations. The diagnostic procedure usually starts with the observation of bulk, possible atrophy or loss of muscle tone. Neuromuscular disease can also be diagnosed by using electrodiagnostic medicine tests including electromyography (measuring electrical activity in muscles) and nerve conduction studies and, by testing the levels of various chemicals and antigens in the blood

  • Track 13-1Neonatal Neuromuscular Disorders
  • Track 13-2Translational Correlation
  • Track 13-3Critical Care Neurology
  • Track 13-4Sleep Disorders
  • Track 13-5Amyotrophic Lateral Sclerosis
  • Track 13-6Muscular Dystrophy
  • Track 13-7Myasthenia Gravis
  • Track 13-8Spinal Muscular Atrophy

The medical specialty concerned with the prevention, diagnosis, surgical treatment, and rehabilitation of disorders which affect any portion of the nervous system including the brain, spinal cord, peripheral nerves, and extra-cranial cerebrovascular system is named as a neurosurgery or neurological surgery.. Crises like intracranial drain and Neuro injury are fundamentally associated with most of the neurosurgery. Intracerebral drain being the primary driver of dismalness and mortality brings about influencing between 37 000 and 52 400 patients every year in the United States. A portion of the pivotal sorts of neurosurgery incorporates vascular neurosurgery and endovascular neurosurgery, stereotactic neurosurgery, practical neurosurgery, and epilepsy surgery, cerebrum tumour, oncological neurosurgery, skull base surgery, spinal neurosurgery, fringe nerve surgery

  • Track 14-1Vascular Neurosurgery
  • Track 14-2Functional Neurosurgery
  • Track 14-3Radiosurgery
  • Track 14-4Peripheral Nerve Surgery
  • Track 14-5Spinal Neurosurgery
  • Track 14-6Neuro Oncology
  • Track 14-7Pediatric Neurosurgery

Neurogenetic and neurometabolic abnormalities disorders affect the functions of brain. These disorders occurs in young children of all ages, races and genders. Neurogenetic disease is the common term of chronic diseases that describes the brain abnormalities that occur following changes within the genes of the child and these cause certain brain cells to develop and function abnormally. In the case of neurometabolic abnormalities; these disorders result from issues in the enzymes of the body’s cells which are either unable to either use foods to produce the energy the cell needs, or get rid of the breakdown products of the foods used

  • Track 15-1Clinical Aspects of Neurometabolic Disorders
  • Track 15-2Biochemical Genetics
  • Track 15-3Gene Mutation and Disease
  • Track 15-4Neural Engineering
  • Track 15-5Genetic Engineering and Gene Sequencing
  • Track 15-6Emerging Treatment of Neurometabolic Disorders
  • Track 15-7Cancer Neurogenetics

The most common issues in the diagnosis and treatment of different disorders are the efficacy, cellular uptake and specific transport of drugs and/or imaging agents to target organs, tissues and cells are. The major problem in the case of neurodegenerative diseases is that the brain targeting remains an unsolved challenge in pharmacology, due to the presence of the blood-brain barrier, a tightly packed layer of endothelial cells that prevents unwanted substances to enter the brain. The physico-chemical features of the engineered nanomaterials, objects with dimensions of 1-100 nm, are providing interesting biomedical tools potentially able to solve these problems. The nanomaterials offer the possibility of multi-functionalization, allowing to confer them different features at the same time, including the ability to cross the blood-brain barrier. Many investigations have shown that these nanomaterials are suitable for therapy and diagnostic imaging of the most common neurodegenerative disorders, as well as for neuroprotection and neuronal tissue regeneration

  • Track 16-1Micellar Nanocarriers
  • Track 16-2Superparamagnetic Iron Oxide Nanoparticles
  • Track 16-3Nanotheranostics
  • Track 16-4Enhanced Magnetic Resonance Imaging
  • Track 16-5Drug Delivery Systems
  • Track 16-6Multimodal Imaging Approaches

Researchers and physicians have used a variety of imaging techniques and chemical to diagnosis a neurological disease.  Following diagnosis, many treatment methods, including medications (topical, oral, and intravenous), device-based therapies (such as deep brain stimulation), surgeries (such as procedures to remove tumours), physical therapy, and rehabilitation shows a promising result for efficient treatment of neurological diseases. Clinical skill, cutting-edge research, and personalized attention are the major requirement to provide comprehensive care for a range of neuropsychological disorders and conditions. This conference is a best platform to increase extra profound experiences into the accepted procedures in clinical trials, and breakthrough the difficulties in Stroke and Neurology and taking a glimpse at the most recent preclinical and clinical studies

  • Track 17-1Stem Cells and Treatment
  • Track 17-2Nerve Injury and Repair
  • Track 17-3Clinical Case Reports
  • Track 17-4Cell and Gene-Based Approach
  • Track 17-5Neurotransmitter Release and Cell Repair
  • Track 17-6Biomarkers
  • Track 17-7Neurophysiotherapy